Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00265928
Status:
TERMINATED
Last Update Posted:
2008-01-28
First Post:
2005-12-14
Brief Title:
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma
Sponsor:
University of Virginia
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Waldenstroms macroglobulinemia | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| splenic marginal zone lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| nodal marginal zone B-cell lymphoma | View |